Roche Global Media Relations Phone: +41 61 688 8888 / e-mail:media.relations@roche.com Roche Investor Relations Investor Relations North America Loren Kalm Phone: +1 650 225 3217 e-mail:kalm.loren@gene.com
Roche Global Media Relations Phone: +41 61 688 8888 / e-mail:media.relations@roche.com Roche Investor Relations
由AZ研发的AKT抑制剂Capivasertib,在10月宣布达到主要临床终点,本次会议上首次公布了这个三期临床的具体数据。 https://www.astrazeneca.com/content/dam/az/Investor_Relations/events/AstraZeneca-SABCS-2022-IR-Presentation-08-Dec-2022.pdf 该试验共入组了708例HR...
After the presentation, there will be a question-and-answer session [Operator Instructions] One last remark, if you'd like to follow the presented slides on your end as well. Please feel free to go to roche.com/investors to download the presentation. At this time, it's my pleasure to i...
Investor Call A conference call and webcast will be held at 8AM ET on Monday, October 23, 2023, to discuss this transaction. To access the conference call by phone, please register online using thisregistration link. The presentation and webcast details will be available under ...
For more details on the transaction, please refer to the related Investor Presentation. Investor Call Details Lonza invites investors to join a live webcast and conference call at 14:00 CET on 20 March 2024. Access to Webcast In order to follow the slide presentation and the Q&A session, ...
All trademarks used or mentioned in this release are protected by law. Roche Group Media Relations Phone: +41 61 688 8888 / e-mail:media.relations@roche.com Roche Investor Relations
Investor presentation Q3 2023 Appendix with Tables Q3 2023 About Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnolo...